Health-related quality of life (HRQL) in patients with advanced cutaneous squamous cell carcinoma (CSCC) treated with cemiplimab: Post hoc exploratory analyses of a phase II clinical trial

MLA

Vera Mastey, et al. “Health-Related Quality of Life (HRQL) in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC) Treated with Cemiplimab: Post Hoc Exploratory Analyses of a Phase II Clinical Trial.” Journal of Clinical Oncology, vol. 38, May 2020, p. 10033. EBSCOhost, https://doi.org/10.1200/jco.2020.38.15_suppl.10033.

APA

Vera Mastey, Chieh-I Chen, Anne Lynn S. Chang, Sherrif F. Ibrahim, Medha Sasane, Anna C. Pavlick, Alexander Guminski, Michael R. Migden, Israel Lowy, Denise Bury, Axel Hauschild, Matthew G. Fury, Guilherme Rabinowits, Siyu Li, Danny Rischin, Chrysalyne D. Schmults, & Zhen Chen. (2020). Health-related quality of life (HRQL) in patients with advanced cutaneous squamous cell carcinoma (CSCC) treated with cemiplimab: Post hoc exploratory analyses of a phase II clinical trial. Journal of Clinical Oncology, 38, 10033. https://doi.org/10.1200/jco.2020.38.15_suppl.10033

Chicago

Vera Mastey, Chieh-I Chen, Anne Lynn S. Chang, Sherrif F. Ibrahim, Medha Sasane, Anna C. Pavlick, Alexander Guminski, et al. 2020. “Health-Related Quality of Life (HRQL) in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC) Treated with Cemiplimab: Post Hoc Exploratory Analyses of a Phase II Clinical Trial.” Journal of Clinical Oncology 38 (May): 10033. doi:10.1200/jco.2020.38.15_suppl.10033.